---
title: "EVAX.US (EVAX.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/EVAX.US/news.md"
symbol: "EVAX.US"
name: "EVAX.US"
parent: "https://longbridge.com/en/quote/EVAX.US.md"
datetime: "2026-05-20T01:40:19.601Z"
locales:
  - [en](https://longbridge.com/en/quote/EVAX.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/EVAX.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/EVAX.US/news.md)
---

# EVAX.US (EVAX.US) — Related News

### [European Equities Traded in the US as American Depositary Receipts Open Week Tracking Higher in Monday Trading](https://longbridge.com/en/news/286794388.md)
*2026-05-18T15:11:00.000Z*
> European equities traded in the US as American depositary receipts rose 0.88% to 1,825.10 on the S&P Europe Select ADR I

### [European Equities Traded in the US as American Depositary Receipts Flat in Wednesday Trading](https://longbridge.com/en/news/286287063.md)
*2026-05-13T15:12:00.000Z*
> European equities traded in the US as American depositary receipts saw a slight increase of 0.08% to 1,829.64 on the S&P

### [Evaxion to present new data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia, at the EHA 2026 Congress | EVAX Stock News](https://longbridge.com/en/news/286109610.md)
*2026-05-12T05:30:46.000Z*
> Evaxion to present new data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia, at the EHA 2026

### [Michael Okunewitch Initiates Buy on Evaxion, Citing Strong Clinical Data, AI-Driven Vaccine Platform, and Cash Runway to 2H 2027](https://longbridge.com/en/news/285777716.md)
*2026-05-08T21:15:21.000Z*
> Maxim Group analyst Michael Okunewitch has initiated a Buy rating on Evaxion (EVAX), citing strong clinical data, an AI-

### [European Equities Traded in the US as American Depositary Receipts Rise Friday](https://longbridge.com/en/news/285749147.md)
*2026-05-08T15:10:00.000Z*
> European equities traded in the US saw a rise in American depositary receipts, increasing 0.78% to 1,826.25 on the S&P E

### [Evaxion (EVAX) Q1 2026 Earnings Transcript](https://longbridge.com/en/news/285605336.md)
*2026-05-07T19:50:32.000Z*
> The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of

### [Evaxion: Buy Rating Reiterated on AI Cancer Vaccine Platform and Upcoming Catalysts; $10 Price Target Unchanged](https://longbridge.com/en/news/284259105.md)
*2026-04-27T18:45:37.000Z*
> Evaxion Biotech received a Buy rating from analyst Debanjana Chatterjee of JonesTrading, maintaining a $10 price target.

### [Evaxion A/S Wins Shareholder Approval for Expanded Equity and Convertible Financing Powers](https://longbridge.com/en/news/283662971.md)
*2026-04-22T11:28:30.000Z*
> Evaxion A/S received shareholder approval for expanded financing powers at its Annual General Meeting on April 16, 2026.